3.73% -1.4874

Anaptysbio Inc (ANAB)

Anaptysbio Inc (ANAB) 最新ニュース

Anaptysbio Inc (ANAB)

Anaptysbio Inc (ANAB) 最新ニュース

TD Asset Management Inc Raises Stock Position in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat

A Guide To The Risks Of Investing In AnaptysBio Inc (ANAB) - Knox Daily

Bioventus Inc [BVS] stock for 683,736 USD was bought by Bartholdson John A. - Knox Daily

Insider Selling: Lizzul Paul F., AnaptysBio Inc [ANAB] Chief Medical Officer divested 2,000 shares - Knox Daily

BTIG Reiterates Buy Rating on Anaptysbio (ANAB) (correction) - StreetInsider.com

AnaptysBio (NASDAQ:ANAB) Shares Down 3.2% - MarketBeat

Analysts Set AnaptysBio, Inc. (NASDAQ:ANAB) Price Target at $50.30 - MarketBeat

AnaptysBio, Inc. (NASDAQ:ANAB) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

Learn to Evaluate (ANAB) using the Charts - Stock Traders Daily

Anaptys Announces Participation in September Investor Conferences - ForexTV.com

Anaptys Announces Participation in September Investor Conferences - Yahoo Finance UK

Anaptys Announces Participation in September Investor Conferences - StockTitan

Why AnaptysBio Was Such a Healthy Stock This Week - sharewise

Why AnaptysBio Was Such a Healthy Stock This Week - Yahoo Finance

Alopecia Areata Clinical Trials 2024: FDA Approvals, Pipeline, - openPR

Contrasting AstraZeneca (NASDAQ:AZN) & AnaptysBio (NASDAQ:ANAB) - Defense World

AnaptysBio Inc (ANAB) receives a Buy rating from H.C. Wainwright - Knoxdaily.com

Hedge Fund and Insider Trading News: Carl Icahn, Ken Griffin, Warren Buffett, Engaged Capital, Elliott Management, Oslo Asset Management, AnaptysBio Inc (ANAB), and More - Insider Monkey

Guggenheim maintains buy on AnaptysBio shares, cites ANAB032 potential By Investing.com - Investing.com Canada

Insiders Buying Yum China And 2 Other Stocks - Benzinga

AnaptysBio, Inc. (NASDAQ:ANAB) Shares Sold by California State Teachers Retirement System - Defense World

Short Interest in AnaptysBio, Inc. (NASDAQ:ANAB) Rises By 9.3% - Defense World

Ecor1 Capital, Llc Buys 273,972 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) Stock - Defense World

AnaptysBio, Inc. (NASDAQ:ANAB) Shares Acquired by Assenagon Asset Management S.A. - MarketBeat

Assenagon Asset Management S.A. Has $7.68 Million Stock Holdings in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World

AnaptysBio, Inc. (NASDAQ:ANAB) Short Interest Update - MarketBeat

Anaptysbio chief medical officer executes stock transactions By Investing.com - Investing.com Australia

Truist Financial Increases AnaptysBio (NASDAQ:ANAB) Price Target to $30.00 - Defense World

AnaptysBio, Inc. to Post Q3 2024 Earnings of ($1.57) Per Share, HC Wainwright Forecasts (NASDAQ:ANAB) - Defense World

AnaptysBio (NASDAQ:ANAB) Stock Price Up 6.6% After Insider Buying Activity - Defense World

AnaptysBio, Inc. (NASDAQ:ANAB) Major Shareholder Ecor1 Capital, Llc Acquires 273,972 Shares - MarketBeat

Public Equity Report: AnaptysBio, Avidity draw nine-digit offerings - BioCentury

Anaptysbio chief medical officer executes stock transactions By Investing.com - Investing.com Canada

Anaptysbio chief medical officer executes stock transactions By Investing.com - Investing.com UK

AnaptysBio (NASDAQ:ANAB) Trading Up 6.6% Following Insider Buying Activity - MarketBeat

Q3 2024 Earnings Forecast for AnaptysBio, Inc. Issued By HC Wainwright (NASDAQ:ANAB) - MarketBeat

Nothing is Better Than AnaptysBio Inc (ANAB) stock at the moment - SETE News

AnaptysBio (NASDAQ:ANAB) Reaches New 12-Month High at $41.11 - Defense World

Metric Analysis: AnaptysBio Inc (ANAB)’s Key Ratios in the Limelight - The Dwinnex

AnaptysBio (NASDAQ:ANAB) Stock Price Down 4.6% - MarketBeat

AnaptysBio: Top-Line AD Data End Of 2024 Could Be Turning Point (NASDAQ:ANAB) - Seeking Alpha

AnaptysBio shares hold rating; price target raised on pipeline programs By Investing.com - Investing.com Canada

AnaptysBio’s (ANAB) Buy Rating Reaffirmed at HC Wainwright - Defense World

AnaptysBio shares hold rating; price target raised on pipeline programs By Investing.com - Investing.com UK

AnaptysBio (NASDAQ:ANAB) Price Target Raised to $30.00 - MarketBeat

AnaptysBio announces pricing of $100 million offering - The Pharma Letter

ANAB’s Financial Health: Exploring AnaptysBio Inc’s Debt-to-Equity Ratio of 1.79 - The InvestChronicle

AnaptysBio (NASDAQ:ANAB) Stock Rating Reaffirmed by HC Wainwright - MarketBeat

AnaptysBio Inc [ANAB] stock was sold by Lizzul Paul F. at the price of US$52500.0 - Knox Daily

AnaptysBio stock soars to 52-week high, hits $38.91 By Investing.com - Investing.com Canada

AnaptysBio (NASDAQ:ANAB) Sets New 12-Month High at $41.11 - MarketBeat

AnaptysBio stock soars to 52-week high, hits $38.91 - Investing.com India

AnaptysBio stock soars to 52-week high, hits $38.91 - Investing.com

AnaptysBio stock soars to 52-week high, hits $38.91 By Investing.com - Investing.com UK

Bicycle Therapeutics (NASDAQ:BCYC) and AnaptysBio (NASDAQ:ANAB) Head-To-Head Analysis - Defense World

Anaptysbio (ANAB) Prices 2.75M Share Offering at $36.50/sh - StreetInsider.com

Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering - ForexTV.com

Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering - StockTitan

Investors in AnaptysBio (NASDAQ:ANAB) have seen respectable returns of 74% over the past year - Yahoo Finance

Vanguard Group Inc. Has $30.49 Million Position in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat

Vanguard Group Inc. Sells 26,112 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World

(ANAB) On The My Stocks Page - Stock Traders Daily

AnaptysBio (NASDAQ:ANAB) PT Raised to $75.00 at JPMorgan Chase & Co. - Defense World

AnaptysBio, Inc. (NASDAQ:ANAB) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World

AnaptysBio, Inc. (NASDAQ:ANAB) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

ANABに似た銘柄